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OBSERVATIONS ON THE USE OF THE GNRH VACCINE GONACONTM
IN MALE WHITE-TAILED DEER (ODOCOILEUS VIRGINIANUS)
G. KILLIAN, Almquist Research Center, The Pennsylvania State University, University Park,
PA, USA
D. WAGNER, Deer Research Center, The Pennsylvania State University, University Park, PA,
USA
L. MILLER, USDA, APHIS, Wildlife Services, National Wildlife Research Center, Fort Collins,
CO, USA
Abstract: Observations made over an 11 year period during the development and evaluation of
the GnRH vaccine GonaConTM use in male white-tailed deer (Odocoileus virginianus) are
summarized. Sexually mature bucks at the Penn State Deer Research Center were administered a
single immunization of GonaConTM in July. Some males were also given a second boost
immunization in September. Compared to similar aged controls, testicular size for treated males
was considerably reduced in the first and subsequent years of study, as were testosterone
concentrations and sexual libido. During the first year, antler development was relatively normal
leading to antler hardening, although shedding occurred early. However, in subsequent years,
antlers were generally smaller, remained in velvet throughout the winter, and froze and then
broke off. Most males given the single immunization returned to breeding condition in 2-3 years,
although they tended to be smaller than similar-aged males. Males given the two immunizations
tended to remain in a treated state longer. Treated males that died during the study had a higher
incidence of pulmonary disease than non-treated males. We conclude that while GonaConTM
reduces the reproductive capacity of male white-tailed deer, the negative effects on health and
antler development make it impractical for field application with bucks.
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evaluating anti-fertility effects of a GnRH
vaccine in mammals have been directed at
livestock and pets (Adams and Adams 1992,
Ladd et al. 1994, Meloen et al. 1994, Rabb
et al. 1990, Robertson 1982, Thompson,
2000). These have largely been short-term
studies to seek alternatives to castration or in
the case of pigs, as a means to reduce boar
taint (Dunshea et al. 2001). Recently
however, we have shown that the GnRH
vaccine
is
effective
in
impairing
reproductive parameters of feral (Killian et

INTRODUCTION
Gonadotropin releasing hormone
(GnRH) vaccines are intended to stimulate
an animal’s immune system to produce
antibodies against GnRH, a small peptide
protein produced by the hypothalamus of the
brain. Because GnRH is responsible for
stimulating
anterior
pituitary
gland
hormones which regulate gamete and
hormone production by the gonads of both
males and females, inactivation of GnRH by
an antibody results in an “immunological”
castration.
Most
published
studies
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interactions among individuals. Hormonal
status, antibody titers, and other blood
parameters also were monitered and body
measurements taken from all subjects. Early
pregnancy was determined by ultrasound
and later confirmed with fawning rates. An
86% reduction in fawning was achieved
during active immunization and a 74%
reduction over 5 years (Miller et al. 2000a,
Killian and Miller 2001). Does given the
GnRH vaccine had reduced progesterone
concentrations, reduced estrous behavior
and evidence of both ovulation failure and
failure to maintain pregnancy following
conception. Infertility lasted up to 2 years
without a booster injection. During the past
11 years we also have evaluated the effects
of the GnRH vaccine in bucks. Although
these studies did not directly evaluate the
effect of the vaccine on individual male
fertility, indirect indicators of their
reproductive status in rut such as plasma
testosterone, testis size, body mass and
antler development were monitored. We
now report the results of these studies with
bucks using this GnRH vaccine.

al. 2003) and domestic boars (Miller et al.
2003).
The effectiveness of a GnRH vaccine
is dependent on having a sustainable
antibody titer which is sufficient to
inactivate endogenous GnRH.
Small
peptides such as GnRH do not provide
adequate stimulus to the immune system to
mount a response. Peptides are typically
coupled to a larger protein which the
immune system will recognize as foreign
and serve as a stimulus for the immune
response. One large protein commonly used
in coupling to stimulate an immune response
to a small peptide is Keyhole Limpet
Hemocyanin (KLH). KLH is a highly
glycosilated mollusk protein which is quite
immunogenic in mammals. The nature of
the
coupling
protein
and
the
vehicle/adjuvant used to inject the vaccine
are the primary determinants of the
magnitude of the antibody titer produced
and its duration. These are important points
to consider during the development of a
long-acting contraceptive vaccine.
The development of a contraceptive
vaccine for wildlife involves an evolving
process by which results of previous
experiments shape the next studies in the
series. Pen studies with white-tailed deer are
expensive, given the initial cost of animals
and maintenance expenses. With limited
resources and budgets, this by necessity
limits the sample size for a given study.
Nevertheless, pen studies enable detailed
sampling at multiple time points on the same
animal which generally provides a fuller
understanding of the animal’s response to a
treatment than is possible in field work.
Our work in this area was initiated in
1994 and subsequently led to the
development and testing of the GnRH
vaccine, GonaConTM. The primary focus of
the effort has been to evaluate the vaccine in
female deer. Does were observed for
reproductive behavior, animal health and

MATERIALS AND METHODS
The study was conducted at the Deer
Research Center at the Pennsylvania State
University over an eleven year period from
1994-2004. All animal procedures were
approved by the Institutional Animal Care
and Use Committee of Penn State. Bucks
were chemically restrained during handling
with 2.2-4.4mg/kg of xylazine administered
IM in the rump. Anesthesia was reversed
with Tolazine at 4mg/kg given IV or IM.
The GnRH vaccine, consisting of the GnRH
peptide
conjugated
to
KLH
was
administered as a single shot, or a single
shot follow by a second immunization.
During the development stage of the
vaccine, the GnRH-KLH component was
administered in a 1 ml dose containing
Freund’s complete adjuvant and mineral oil
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State deer herd. To explore this notion
further, a retrospective analysis was
conducted on the causes of death of
deceased animals determined by veterinary
pathologists at the Pennsylvania State
Animal Diagnostic Lab located on the Penn
State campus. This study was limited to
comparing the causes of death between the
groups rather than the incidence of death for
the populations.

(Miller et al. 2000a). A second
immunization was typically given 4-6 weeks
later using Freund’s incomplete adjuvant.
Preliminary studies evaluated several doses
of the vaccine and compared subcutaneous
versus intra-dermal versus intra-muscular.
From these studies we adopted a standard
protocol dose that utilized 850-1000ug of
GnRH-KLH, injected IM in the rump. The
latter protocol was used in the studies
reported.
Although not observed in the deer
we studied, the formation of granulomatous
lesions caused by FCA at the injection site is
not uncommon in many species vaccinated
with Freund’s. These observations have
caused the USDA to raise the classification
of use of FCA in experimental animals from
a Category C to Category D, among their
definitions of painful procedures. Therefore
we developed an alternative adjuvant called
AdjuVac, which was used in the studies
reported. When AdjuVac was used with
GonaConTM in place of FCA, sustained
antibody titers were observed comparable to
FCA, without any evidence of a tissue
reaction.
Blood samples were collected 5-6
times from July through February from the
jugular vein. After clotting, the serum was
harvested by centrifugation and stored
frozen at -20C until assay. Serum was used
to determine antibody titers to GnRH and
concentration of testosterone using methods
described elsewhere (Levy et al. 2004).
During blood sampling, testis length and
width were determined using calipers, and
body condition and antler development was
noted. If a buck was euthanized during the
study, the testes and epididymides were
removed and prepared for histological
evaluation.
During the 11 year period of study
we developed the general impression that
bucks given the GnRH vaccine were less
healthy than non-treated males in the Penn

RESULTS AND DISCUSSION
Antibody titers for most treated bucks
reached values of 1:128,000 or greater by
10-12 weeks post vaccination, which
coincided with rut. Bucks with titers less
than that in general showed less of an effect
of the vaccine. Bucks receiving the boost
vaccination sustained the 128,000 titer
longer, especially into the second breeding
season. Based on our experience with does
and bucks given the GnRH vaccine in earlier
studies (Miller et al. 2000a), the ability to
obtain a high titer that is sustainable is key
to the vaccine’s ability to inhibit
reproduction.
The most apparent effect of GnRH
vaccine use in bucks was the alteration of
antler development. During the first year
antlers of treated males typically hardened
and the males rubbed out of velvet.
However, antlers of GnRH vaccine treated
males were shed approximately 4-6 weeks
earlier than non-treated controls. If antibody
titers were adequate to suppress testosterone
production by the testis during the second
year following immunization, the antlers
grew but failed to harden. Considering the
normal antler growth cycle of deer (Figure
1) it is evident that as testicular testosterone
increases in mid summer, there is a
corresponding increase in antler growth. The
rise in testosterone is also associated with
antler hardening and shedding of velvet that
occurs prior to rut. During first breeding
season following GnRH vaccine treatment
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hardening, but as the antibody titers rise
there is a drop in testosterone and antlers are
shed prematurely. If antibody titers are
sustained into the second year following
vaccination, the seasonal changes associated
with breeding are prevented because GnRH
secretion is compromised. Consequently,
growth and hardening of antlers facilitated
by testosterone do not occur, and the antlers
tend to be smaller and remain in velvet
throughout the season.

in July, there is a time delay before an effect
is seen. Antlers typically develop and
harden, although they are shed early. This is
a result of the lag time necessary for the
immune system to develop antibody titers
sufficient to complex with most endogenous
GnRH and the subsequent “trickle down
effect” that eventually removes the stimulus
for testicular hormone secretion. During the
first year, testosterone levels are apparently
adequate to sustain development through

Testosterone Levels Compared to Antler Growth Cycle
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Figure 1. Serum testosterone during the normal antler growth cycle of white-tailed deer. From
March through early summer, the primary source of testosterone is the adrenal glands. From mid
summer through February, the primary source of testosterone is the testis.

The effects seen in GnRH-treated
males on antler development, behavior and
body mass are the direct consequence of a
reduction of serum testosterone, which
modulates these characteristics. For treated
bucks in our study, there was a significant
drop in testosterone compared to non-treated
controls (Figure. 3). This drop in
testosterone corresponded to histological
changes in the testis which resembled the
testis of males during the non-breeding
season. In the treated males, the Leydig cells
which produce testosterone appear inactive,
and the seminiferous tubules are regressed
and do not contain mature sperm. These
observations support the conclusion that
these males were infertile.

Another notable effect of the GnRH
vaccine on males was their failure to
develop the muscular appearance typical of
mature bucks in rut, analogous to a weight
lifter on steroids (Figure 2). Removal of
testosterone in GnRH-treated males leaves
them with the body form of a female with
antlers. These males show little or no
interest in estrus does that are penned with
them or in adjacent pens. Infrequently,
GnRH-treated males may attempt to mount a
doe in heat in the absence of control males,
but the mount is not complete. Although we
did not test fertility of the GnRH males in a
breeding trial per se, these observations
suggest that GnRH treated males would not
reproduce successfully.
259
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Figure 2. A comparison of body mass of males in the breeding season a GnRH vaccine treated male
(left) and a control male of similar age.
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Figure 3. Average plasma testosterone concentrations (n=5 males per group) during the breeding
season for control males and males vaccinated with the GnRH vaccine in July.

In practice, the use of any
contraceptive approach with wildlife should
be effective for multiple years, since
opportunities to retreat the same animal will
be unlikely. Contraceptive vaccines using
porcine zona pellucida (PZP) as the
immunogen have been reported to be

effective in does for 1-2 years (Turner et al.
1992; Miller et al, 2000b). In ongoing
studies in our deer herd testing the effect of
the PZP vaccine SpayVac on does, we have
observed 80% contraceptive efficacy after 4
years. Although we have not conducted
extensive long-term studies with the GnRH
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sperm production may have occurred in
some of the bucks. Unfortunately, we did
not examine histology of the testes of all of
the treated males, but based on studies we
have conducted with feral swine (Killian et.
al. 2003, Killian et al, unpublished), it is
certainly possible that some sperm
production could occur. However, the
reduced testicular function of GnRH treated
bucks may not be adequate to assume
successful reproductive function. Moreover,
the failure of antlers to harden, the lack of
interest in estrus does and the female like
body mass suggest that GnRH vaccinetreated males would not be reproductively
active.
Our ability to closely monitor
individual males during the course of these
studies led us to believe that GnRH-treated
males may be less healthy than non-treated
males in the Penn State herd. To explore this
possibility, necropsy reports were examined,
if available, to assess the causes of death for
GnRH-treated and untreated males that died
during the 11 years of study. Causes of
death included bone fractures and associated
infections, enterocolitis and pulmonary
diseases
including
pneumonia,
pleuropneumonia, pulmonary abscession,
and bronchopneumonia. For both the control
and GnRH-treated bucks, pulmonary
diseases were the single greatest cause of
death (Table 3). This agrees with a
published study indicating that in
Pennsylvania captive white-tailed deer,
pulmonary disease was the most common
cause of death (Hattel et al. 2004). For our
study, however, the relative incidence of
death resulting from pulmonary disease in
the treated males was significantly greater
than that for control bucks. We can only
speculate on the reason for this observation.
Microbes associated with pneumonia appear
to be endemic in captive deer herds and
GnRH-treated bucks appear to be less

vaccine in bucks, there is evidence that the
inhibitory effects of the vaccine are present
for multiple years based on testicular size
(Table 1) and plasma testosterone
concentration (Table 2) during rut.
Compared to controls, males receiving the
single or two shot regimen on average had
reduced testicular size and plasma
testosterone for at least three breeding
seasons. In the study with the single shot
vaccine where data were collected in the
fourth year post vaccination, there was
evidence that testicular function was being
restored.
Table 1. Average scrotal testis length in mm
for (n) bucks treated with a single vaccination
of GnRH vaccine (GnRH-1X) or a single
vaccination followed by a boost (GnRH-2X)
compared to untreated control males.
Year Year Year Year
Treatment
1
2
3
4
Controls

74(3)

-

-

-

GnRH-1X

44(5)

38(5)

58(3)

65(2)

GnRH-2X

40(5)

46(3)

39(3)

-

Table 2. Average ng of serum testosterone
for (n) bucks treated with a single vaccination
of GnRH vaccine (GnRH-1X) or a single
vaccination followed by a boost (GnRH-2X)
compared to untreated control males.
Year Year
Treatment Year 1
Year 4
2
3
Control

603(3)

-

-

-

GnRH-1X

6(5)

28(5)

10(3)

175(2)

GnRH-2X

30(5)

23(3)

50(3)

Data on testicular function must be
interpreted somewhat cautiously however,
when predicting male fertility. It is possible
that while average testicular size and plasma
testosterone were reduced, some level of

261

J. WALKER, AND D.P. HENNESSY. 2001.
Vaccination of boars with a GnRH
vaccine (Improvac) eliminates boar taint
and increases growth performance.
Journal of Animal Science 79:25242535.
HATTEL, A.L., D.P. SHAW, B.C. LOVE,
D.C.WAGNER, T.R. DRAKE, AND J.W.
BROOKS. 2004. A retrospective study
of mortality in Pennsylvania captive
white-tailed
deer
(Odocoileus
virginianus): 2000-2003. Journal of
Veterinary Diagnostic Investigation
16:515-521.
KILLIAN, G.J., AND L.A. MILLER.
2001.
Behavioral
observations
and
physiological implications for whitetailed deer treated with two different
immuocontraceptives. Proceedings of
the Wildlife Damage Management
Conference 9:283-291.
_____, _____, J. RHYAN, T. DEES, AND H.
DOTEN. 2003. Evaluation of GnRH
contraceptive vaccine in captive feral
swine in Florida. Proceedings of the
Wildlife
Damage
Management
Conference 10:128-133.
LADD, A., Y.Y. TSONG, A.M. WALFIELD, AND
R. THAU. 1994. Development of an
antifertility vaccine for pets based on
active immunization against luteinizing
hormone-releasing hormone. Biology of
Reproduction 51:1076-83.
LEVY, J.K, L.A. MILLER, C. CRAWFORD, M.K.
ROSS, K.A. FAGERSTONE, AND H.L.
JORDAN.
2004. GnRH immunocontraception
of
male
cats.
Theriogenology 62: 1116-1130.
MELOEN, R.H., J.A. TURKSTRA, H. LANKHOF,
W.C. PUIJK, W.M.M. SCHAAPER, G.
DIJKSTRA, C.J.G. WENSING, AND R.B.
OONK.
1994.
Efficient immunocastration
of
male
piglets
by
immunoneutralization of GnRH using a
new GnRH-like peptide.
Vaccine
12:741-746.
MILLER, L.A., B.E. JOHNS, AND G.J. KILLIAN.
2000a. Immunocontraception of whitetailed deer with GnRH vaccine.
American
Journal of Reproductive
Immunology 44:266-274.

resistant to infections caused by these
microbes.
Table 3. Causes of Mortality for Bucks at
PSU Deer Research Center 1994-2004.
Pulmonary diseases included pneumonia,
plueropneumonia, pulmonary abscession, and
bronchopneumonia. Other causes included
enterocolitis and bone fractures and
associated infections as the primary causes of
mortality.

Controls
n=22

GnRHtreated
n=13

Pulmonary
Disease

41%

62%**

Other

59%

38%

**Significant p <.05 by Chi square.

CONCLUSIONS
We have demonstrated that both
single and two injection protocols of
GonaConTM were effective in altering
reproductive function of male white-tailed
deer for multiple years. Plasma testosterone,
testis size, breeding behavior and body mass
were all reduced in GnRH vaccine treated
males compared to non-treated males. In
addition, antler development was reduced,
antlers failed to harden and mortality due to
pulmonary disease was greater in treated
males. Although GonaConTM was effective
in impairing reproductive function, given the
latter considerations we do not recommend
its use for controlling fertility of bucks.
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